UK Daily Mail "Two coronavirus patients in New York City were treated with a new drug 'fast-tracked' for HIV and breast cancer - and they went from being on ventilators in the ICU to regular hospital in a matter of days.
"Based on the results of a small initial trial, biotech firm CytoDyn believes their drug, leronlimab, has potential for treating patients severely ill with coronavirus.
"They believe that the drug can quell the 'cytokine storm' - a deluge of immune cells that can be as damaging as the infection itself - that triggers life-threatening lung inflammation in coronavirus patients.
"Leronlimab has only been tested in seven critically ill patients thus far, but two are now free from ventilators, and another two more show signs that the severe inflammation sending their lungs into organ failure are subsiding.
"There are no approved treatments for coronavirus, but the CytoDyn's drug is among the latest being tested to help save the lives of Americans with coronavirus, of which there are now well over 100,000 - and if it continues to show promise it could get FDA approval in as little as little as six weeks.
"Developing a drug that targets the coronavirus itself take time and money - both of which are in short supply in the face of the COVID-19 pandemic.
"Scientists, universities, and the World Health Organization are all racing to test existing drugs or those in development against the virus that has already killed more than 1,500 Americans.
"Among those is a drug that has already been fast-tracked by the US Food and Drug Administration for treating another virus - HIV - as well as cancer.
Leronlimab is already in trials and showing promise for treating HIV." . . .More
No comments:
Post a Comment